台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

(ME2-2) The role of cytoreductive nephrectomy for metastatic renal cell carcinoma in the immunotherapy era_黃子豪

2022-01-17 • 觀看: 9 • 回應: 0 • 影片
(TSG-1) Treatment strategy in recurrent non-muscle-invasive bladder cancer_王紹全

2022-01-14 • 觀看: 14 • 回應: 0 • 影片
(TSG-4) Feasibility and efficacy of neoadjuvant nivolumab+ipilimumab in patients with MIBC_黃立華

2022-01-14 • 觀看: 4 • 回應: 0 • 影片
(TSG-3) Current status and future of IO in locally advanced urothelial carcinoma_羅浩倫

2022-01-14 • 觀看: 12 • 回應: 0 • 影片
(TSG-2) Perioperative IO in urothelial carcinoma_魏子鈞

2022-01-14 • 觀看: 12 • 回應: 0 • 影片
(ME2-1) The evolving therapeutic landscape in the golden age for the care of mRCC _Jens Bedke

2022-01-14 • 觀看: 11 • 回應: 0 • 影片
(TSD-3) High-dose chemotherapy and stem cell transplant for testicular cancer_陳建廷

2022-01-14 • 觀看: 4 • 回應: 0 • 影片
(TSD-2) The role & tricks of LNs dissection in treatment_陳盈伸

2022-01-14 • 觀看: 5 • 回應: 0 • 影片
(TSD-1) The role of diagnostic imaging in the primary testicular cancer: Initial staging, response assessment and surveillance_廖丞晞

2022-01-14 • 觀看: 3 • 回應: 0 • 影片
(TSC-4) Is prior concomitant bladder UC a significant prognostic factor for UTUC? _戴定恩

2022-01-14 • 觀看: 6 • 回應: 0 • 影片
(TSC-3) Does endoscopic upper tract tumor biopsy increases subsequent bladder UC risk after RNU? A nationwide multi-center cohort study_吳佳璋

2022-01-14 • 觀看: 3 • 回應: 0 • 影片
(TSC-2) Prognostic significance of primary tumor location in UTUC: A retrospective multi-center cohort study in Taiwan_葉信志

2022-01-14 • 觀看: 5 • 回應: 0 • 影片

Prev
437
438
439
440
441
442
443
444
445
446
Next
/ 1052